Omalizumab for the treatment of allergic rhinitis: a systematic review and meta-analysis.
Sign Up to like & getrecommendations! Published in 2021 at "Rhinology"
DOI: 10.4193/rhin21.159
Abstract: BACKGROUND Allergic rhinitis (AR), an IgE mediated inflammatory disease, significantly impacts quality of life of a considerable proportion of the general population. Omalizumab, a humanized monoclonal antibody against IgE, has been evaluated for both seasonal… read more here.
Keywords: allergic rhinitis; meta analysis; summary standardized; rhinitis ... See more keywords